• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 16, 2024
Discovery & Translation

Science Spotlight: Better genomic predictors for Black AML patients 

BioCentury’s roundup of translational innovations also includes a method for continuous base edits, plus updates from Monte Rosa and ImCheck
Read More
BioCentury | Mar 4, 2022
Distillery Therapeutics

Neddylation inhibition for insulin resistance

Read More
BioCentury | Jul 10, 2018
Distillery Therapeutics

Endocrine/Metabolic

Read More
BioCentury | May 1, 2018
Distillery Therapeutics

Cancer

Read More
BioCentury | Jan 20, 2017
Company News

TyrNovo, Kitov deal

Read More
BioCentury | Jul 28, 2016
Distillery Therapeutics

Therapeutics: Insulin receptor substrate 1 (IRS1); K-Ras (KRAS); Janus kinase-1 (JAK-1); JAK-2

Read More
BioCentury | May 19, 2014
Clinical News

Aganirsen: Phase III data

Read More
BioCentury | May 13, 2014
Clinical News

Gene Signal publishes mixed data for aganirsen

Read More
BioCentury | Apr 28, 2014
Clinical News

Aganirsen: Phase IIa data

Read More
BioCentury | May 23, 2013
Distillery Therapeutics

Indication: Cancer

Read More
Items per page:
1 - 10 of 22